IGM Biosciences
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $516 | $1,254 | $497 | $651 |
Gross Profit | 516 | -1,022 | -1,679 | -1,530 |
EBITDA | -62,080 | -49,081 | -51,680 | -63,447 |
EBIT | -64,387 | -51,357 | -53,856 | -65,628 |
Net Income | -61,430 | -47,902 | -49,816 | -60,695 |
Net Change In Cash | 516 | 1,254 | 497 | 651 |
Free Cash Flow | -39,677 | -38,588 | -44,901 | -49,456 |
Cash | 42,875 | 67,263 | 79,498 | 113,112 |
Basic Shares | 60,657 | 60,434 | 60,114 | 59,829 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $2,130 | $1,069 | $366 | $0 |
Gross Profit | -6,147 | 1,069 | -7,724 | -3,576 |
EBITDA | -253,358 | -221,881 | -160,839 | -82,255 |
EBIT | -261,635 | -227,956 | -165,323 | -83,280 |
Net Income | -246,416 | -214,248 | -160,680 | -80,330 |
Net Change In Cash | 2,130 | 1,069 | 366 | 0 |
Cost of Revenue | -107,045 | 205,189 | ||
Free Cash Flow | -204,612 | -16,059 | -137,583 | -84,805 |
Cash | 112,520 | 121,231 | 133,334 | 241,080 |
Basic Shares | 52,311 | 41,543 | 33,479 | 30,748 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.01 |
2024-06-30 | -$0.79 |
2024-03-31 | -$0.83 |
2023-12-31 | -$1.01 |
